Both in Pharmaceuticals
Phibro Animal Health vs Nuvation Bio
Over the past year PAHC returned −5.7% and NUVB returned −9.3%; their daily moves had a correlation of 0.08.
PAHC −5.7% NUVB −9.3%Growth of $1, one year, split-adjusted
| Metric | PAHC | NUVB |
|---|---|---|
| Price | $38.86 | $4.77 |
| Market cap | $1.58B | $1.67B |
| Today | +2.59% | +3.92% |
| 1 month | +8.7% | −14.8% |
| 6 months | −26.9% | +7.2% |
| Year to date | +4.0% | −46.8% |
| 1 year | −6.8% | −11.2% |
| Revenue growth (YoY) | +4.8% | +555.6% |
| Gross margin | 33.9% | 73.0% |
| Net margin | 5.5% | −198.3% |
| P/E (TTM) | 15.8× | — |
| Price / sales | 1.0× | 9.9× |
| Net cash | -$650.8M | $399.4M |
| Dividend yield | 1.24% | — |
| Volatility (60d) | 30.6% | 53.7% |
| Short % of float | 4.9% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).